Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business
Debaroti Adhikary

Zydus Lifesciences shares drop 3% after Q1 earnings. Here's why Nuvama upgraded rating, hiked target

Shares of Zydus Lifesciences fell over 2% to Rs 1,151 on the BSE in Wednesday's early trade after the company reported a 36% year-on-year decline in consolidated net profit to Rs 939.8 crore for the first quarter of FY27, compared with Rs 1,467 crore in the year-ago quarter.

Zydus Lifesciences had announced its results on Tuesday, following which the stock rallied over 6% to close at Rs 1,191 apiece.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.